<HTML>
<HEAD>
<META NAME="Generator" CONTENT="Microsoft Word 97">
<TITLE>FORM 8-K</TITLE>
</HEAD>
<BODY LINK="#0000ff">

<B><FONT FACE="CG Times,Times New Roman"><P ALIGN="CENTER">UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
Washington, D.C.  20549</P>
</B><P ALIGN="CENTER"></P>
<B><P ALIGN="CENTER">FORM 8-K</P>
</B><P ALIGN="CENTER"></P>
<B><P ALIGN="CENTER">CURRENT REPORT<BR>
Pursuant to Section 13 or 15(d) of the<BR>
Securities Exchange Act of 1934</P>
</B><P ALIGN="CENTER"></P>
<P ALIGN="CENTER">Date of Report (Date of earliest event reported): February 1, 2005</P>

<P>&nbsp;</P>
<U><P ALIGN="CENTER">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mediware Information Systems, Inc.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<BR>
</U></FONT><FONT FACE="CG Times,Times New Roman" SIZE=2>(Exact name of registrant as specified in its charter)</P>
</FONT><FONT FACE="CG Times,Times New Roman"><P><BR>
</P></FONT>
<P ALIGN="CENTER"><CENTER><TABLE CELLSPACING=0 BORDER=0 CELLPADDING=7 WIDTH=638>
<TR><TD VALIGN="TOP" COLSPAN=4>
<U><P ALIGN="CENTER">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;New York&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1-10768&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11-2209324&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
</TR>
<TR><TD WIDTH="33%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER">(State or other jurisdiction<BR>
of incorporation)</FONT></TD>
<TD WIDTH="29%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER">(Commission File Number)</FONT></TD>
<TD WIDTH="38%" VALIGN="TOP" COLSPAN=2>
<FONT SIZE=2><P ALIGN="CENTER">(IRS Employer<BR>
Identification No.)</FONT></TD>
</TR>
<TR><TD VALIGN="TOP" COLSPAN=4>
<P ALIGN="CENTER">&nbsp;</P>
<U><P ALIGN="CENTER">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11711 West 79th Street, Lenexa, KS&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;66214&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
</TR>
<TR><TD WIDTH="63%" VALIGN="TOP" COLSPAN=3>
<FONT SIZE=2><P ALIGN="CENTER">(Address of principal executive offices)</FONT></TD>
<TD WIDTH="37%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER">(Zip Code)</FONT></TD>
</TR>
<TR><TD VALIGN="TOP" COLSPAN=4>&nbsp;</TD>
</TR>
<TR><TD VALIGN="TOP" COLSPAN=4>
<FONT FACE="CG Times,Times New Roman"><P ALIGN="CENTER">Registrant's telephone number, including area code<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(913) 307-1000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>
</U></FONT><FONT SIZE=2></FONT></TD>
</TR>
</TABLE>
</CENTER></P>

<U><P ALIGN="CENTER">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<BR>
</U>(Former name or former address, if changed since last report)</P>
<P ALIGN="CENTER"></P>
<P ALIGN="CENTER">&nbsp;</P><DIR>
<DIR>

<FONT SIZE=1><P>Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P>[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</P>

<P>[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</P>

<P>[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</P>

<P>[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</P>

</FONT><FONT FACE="CG Times,Times New Roman"><P>&nbsp;</P>
</FONT><P>Item 2.02&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Results of Operations and Financial Condition</P>
<P ALIGN="JUSTIFY"></P><DIR>
<DIR>

<P ALIGN="JUSTIFY">&nbsp;&nbsp;On February 1, 2005, the Company issued a press release announcing its<BR>
&nbsp;&nbsp;financial results for the quarter ended December 31, 2004.  The press release is<BR>
&nbsp;&nbsp;attached hereto as Exhibit 99.1.  This information shall not be deemed "filed"<BR>
&nbsp;&nbsp;for purposes of Section 18 of the Securities Exchange Act of 1934, as amended,<BR>
&nbsp;&nbsp;and is not incorporated by reference into any filing of the Company, whether<BR>
&nbsp;&nbsp;made before or after the date of this report, regardless of any general<BR>
&nbsp;&nbsp;incorporation language in the filing.</P></DIR>
</DIR>

<P><BR>
Item 9.01&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Financial Statements and Exhibits.</P>

<P>(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exhibits.</P>

<P>Exhibit 99.1&nbsp;&nbsp;&nbsp;&nbsp;Press Release of Mediware Information Systems, Inc., dated February 1, 2005,<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;announcing its financial results for the quarter ended December 31, 2004.</P>

<FONT FACE="CG Times,Times New Roman"><P>&nbsp;</P>
<P>&nbsp;</P></DIR>
</DIR>

<B><P ALIGN="CENTER">SIGNATURES</P>
</B><P><BR>
</P>
<P>Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P>&nbsp;</P></FONT>
<P ALIGN="CENTER"><CENTER><TABLE CELLSPACING=0 BORDER=0 CELLPADDING=7 WIDTH=615>
<TR><TD WIDTH="45%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="55%" VALIGN="TOP">
<FONT FACE="CG Times,Times New Roman"><P>MEDIWARE INFORMATION SYSTEMS, INC</FONT></TD>
</TR>
<TR><TD WIDTH="45%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="55%" VALIGN="TOP">&nbsp;</TD>
</TR>
<TR><TD WIDTH="45%" VALIGN="TOP">
<FONT FACE="CG Times,Times New Roman"><P>Date:&#9;February 1, 2005</FONT></TD>
<TD WIDTH="55%" VALIGN="TOP">
<FONT FACE="CG Times,Times New Roman"><P>By:&nbsp;&nbsp;<U>/s/ George J. Barry<BR>
</U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;George J. Barry<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chief Executive Officer and President</FONT></TD>
</TR>
</TABLE>
</CENTER></P>

<FONT FACE="CG Times,Times New Roman">
<P>&nbsp;</P>
<P>&nbsp;</P>
<B><U><P ALIGN="CENTER">EXHIBIT INDEX</P>
<P ALIGN="CENTER"></P>
</B></U><P>&nbsp;</P></FONT>
<P ALIGN="CENTER"><CENTER><TABLE CELLSPACING=0 BORDER=0 CELLPADDING=7 WIDTH=638>
<TR><TD WIDTH="31%" VALIGN="TOP">
<U><FONT FACE="CG Times,Times New Roman"><P>Exhibit No.</U><BR>
</FONT></TD>
<TD WIDTH="69%" VALIGN="TOP">
<U><FONT FACE="CG Times,Times New Roman"><P>Description<BR>
</U></FONT></TD>
</TR>
<TR><TD WIDTH="31%" VALIGN="TOP">
<FONT FACE="CG Times,Times New Roman"><P>99.1</FONT></TD>
<TD WIDTH="69%" VALIGN="TOP">
<FONT FACE="CG Times,Times New Roman"><P>Press Release of Mediware Information Systems, Inc., dated February 1, 2005, announcing its financial results for the quarter ended December 31, 2004.</FONT></TD>
</TR>
</TABLE>
</CENTER></P>

<FONT FACE="CG Times,Times New Roman">
<P ALIGN="RIGHT">&nbsp;</P>
</FONT><B><P ALIGN="RIGHT">EXHIBIT 99.1</P>
</B>
<I><FONT SIZE=1><P>&nbsp;</P></I></FONT>
<P ALIGN="CENTER"><CENTER><TABLE CELLSPACING=0 BORDER=0 CELLPADDING=7 WIDTH=513>
<TR><TD WIDTH="33%" VALIGN="TOP">
<B><U><FONT SIZE=2><P>Contact</B></U></FONT></TD>
<TD WIDTH="33%" VALIGN="TOP">
<B><U><FONT SIZE=2><P>George Barry<BR>
913/307-1000<BR>
www.mediware.com</B></U></FONT></TD>
<TD WIDTH="33%" VALIGN="TOP">
<B><U><FONT SIZE=2><P>Thomas Redington<BR>
203/222-7399<BR>
212/926-1733<BR>
www.redingtoninc.com</B></U></FONT></TD>
</TR>
</TABLE>
</CENTER></P>

<B><P ALIGN="CENTER"></P>
<P ALIGN="CENTER">&nbsp;</P><DIR>
<DIR>
<DIR>

<U><P ALIGN="CENTER">Mediware Reports Second Quarter Fiscal 2005 Results</P>
</U><P ALIGN="CENTER"><BR>
</P>
<P ALIGN="JUSTIFY">LENEXA, KS FEB. 1 -- </B>Mediware Information Systems, Inc. (Nasdaq: MEDW) said revenue for its second fiscal quarter ended December 31, 2004 was $9.2 million, up 1 percent from the year-ago quarter.  Net income was $949,000, or 12 cents per basic and diluted share, compared to $973,000, or 13 cents per basic and 12 cents per diluted share, a year ago.</P>
<P ALIGN="JUSTIFY">The Company reported that new product launches underway at all its divisions are experiencing increased levels of prospective customer interest.   </P>
<P ALIGN="JUSTIFY">&quot;Order flow and installs of new blood banking systems are increasing in accordance with internal targets,&quot; said George Barry, Mediware's CEO, &quot;and we expect pharmacy system roll-outs in the U.K. to increase over sequential quarters.  The Company has increased its marketing focus which, in combination with the availability of referenceable Medication Management System (MediMAR&trade; and MediCOE&trade;) installs, should move the Division toward achieving forecasted levels.&quot; </P>
<P ALIGN="JUSTIFY">On a broader note, he added, &quot;we were delighted to learn that the Bush administration last week renewed its pledge to accelerate broader adoption of computerized health and prescription records.  The national goal is to reduce medical errors, and that bodes well for Mediware's strategy and product lines.&quot;</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&nbsp;</P></DIR>
</DIR>
</DIR>

<P ALIGN="CENTER"><CENTER><TABLE BORDER CELLSPACING=1 CELLPADDING=7 WIDTH=594>
<TR><TD VALIGN="TOP" COLSPAN=5>
<B><FONT SIZE=3><P ALIGN="CENTER">Three and six months ended December 31, 2004 and 2003 Condensed Consolidated<BR>
Statement of Operations Highlights<BR>
(in thousands, except net income per share) (unaudited):</B></FONT></TD>
</TR>
<TR><TD VALIGN="TOP" COLSPAN=5>&nbsp;</TD>
</TR>
<TR><TD WIDTH="45%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="28%" VALIGN="TOP" COLSPAN=2>
<FONT SIZE=3><P ALIGN="CENTER">Three Months Ended<BR>
December 31</FONT></TD>
<TD WIDTH="26%" VALIGN="TOP" COLSPAN=2>
<FONT SIZE=3><P ALIGN="CENTER">Six Months Ended<BR>
December 31</FONT></TD>
</TR>
<TR><TD WIDTH="45%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="15%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">   <U>2004</U></FONT></TD>
<TD WIDTH="14%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">   <U>2003</U></FONT></TD>
<TD WIDTH="13%" VALIGN="MIDDLE">
<U><FONT SIZE=3><P ALIGN="RIGHT">2004</U></FONT></TD>
<TD WIDTH="13%" VALIGN="MIDDLE">
<U><FONT SIZE=3><P ALIGN="RIGHT">2003</U></FONT></TD>
</TR>
<TR><TD WIDTH="45%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="15%" VALIGN="MIDDLE">&nbsp;</TD>
<TD WIDTH="14%" VALIGN="MIDDLE">&nbsp;</TD>
<TD WIDTH="13%" VALIGN="MIDDLE">&nbsp;</TD>
<TD WIDTH="13%" VALIGN="MIDDLE">&nbsp;</TD>
</TR>
<TR><TD WIDTH="45%" VALIGN="TOP">
<FONT SIZE=3><P>&nbsp;&nbsp;System Sales</FONT></TD>
<TD WIDTH="15%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$&nbsp;&nbsp;2,676 </FONT></TD>
<TD WIDTH="14%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$&nbsp;&nbsp;3,102 </FONT></TD>
<TD WIDTH="13%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$&nbsp;&nbsp;5,217</FONT></TD>
<TD WIDTH="13%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$&nbsp;&nbsp;5,840</FONT></TD>
</TR>
<TR><TD WIDTH="45%" VALIGN="TOP">
<FONT SIZE=3><P>&nbsp;&nbsp;Services</FONT></TD>
<TD WIDTH="15%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">  6,550 </FONT></TD>
<TD WIDTH="14%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">  6,007 </FONT></TD>
<TD WIDTH="13%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">  12,489</FONT></TD>
<TD WIDTH="13%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">  12,280</FONT></TD>
</TR>
<TR><TD WIDTH="45%" VALIGN="TOP">
<FONT SIZE=3><P>Total Revenue</FONT></TD>
<TD WIDTH="15%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">  9,226</FONT></TD>
<TD WIDTH="14%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">  9,109</FONT></TD>
<TD WIDTH="13%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">  17,706</FONT></TD>
<TD WIDTH="13%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">  18,120</FONT></TD>
</TR>
<TR><TD WIDTH="45%" VALIGN="TOP">
<FONT SIZE=3><P>   Operating Expenses</FONT></TD>
<TD WIDTH="15%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">  7,717</FONT></TD>
<TD WIDTH="14%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">  7,634</FONT></TD>
<TD WIDTH="13%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">  15,165</FONT></TD>
<TD WIDTH="13%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">  14,737</FONT></TD>
</TR>
<TR><TD WIDTH="45%" VALIGN="TOP">
<FONT SIZE=3><P>Operating Income </FONT></TD>
<TD WIDTH="15%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">  1,509 </FONT></TD>
<TD WIDTH="14%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">  1,475 </FONT></TD>
<TD WIDTH="13%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">    2,541</FONT></TD>
<TD WIDTH="13%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">    3,383</FONT></TD>
</TR>
<TR><TD WIDTH="45%" VALIGN="TOP">
<FONT SIZE=3><P>Net Income </FONT></TD>
<TD WIDTH="15%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">     949</FONT></TD>
<TD WIDTH="14%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">     973</FONT></TD>
<TD WIDTH="13%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">    1,592</FONT></TD>
<TD WIDTH="13%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">    2,171</FONT></TD>
</TR>
<TR><TD WIDTH="45%" VALIGN="TOP">
<FONT SIZE=3><P>Net Income per Common Share:</FONT></TD>
<TD WIDTH="15%" VALIGN="MIDDLE">&nbsp;</TD>
<TD WIDTH="14%" VALIGN="MIDDLE">&nbsp;</TD>
<TD WIDTH="13%" VALIGN="MIDDLE">&nbsp;</TD>
<TD WIDTH="13%" VALIGN="MIDDLE">&nbsp;</TD>
</TR>
<TR><TD WIDTH="45%" VALIGN="TOP">
<FONT SIZE=3><P>   Basic</FONT></TD>
<TD WIDTH="15%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$&nbsp;&nbsp;&nbsp;0.12</FONT></TD>
<TD WIDTH="14%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$&nbsp;&nbsp;&nbsp;0.13</FONT></TD>
<TD WIDTH="13%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$&nbsp;&nbsp;&nbsp;0.20</FONT></TD>
<TD WIDTH="13%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$&nbsp;&nbsp;&nbsp;0.29</FONT></TD>
</TR>
<TR><TD WIDTH="45%" VALIGN="TOP">
<FONT SIZE=3><P>   Diluted</FONT></TD>
<TD WIDTH="15%" VALIGN="TOP">
<FONT SIZE=3><P ALIGN="RIGHT">$&nbsp;&nbsp;&nbsp;0.12</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP">
<FONT SIZE=3><P ALIGN="RIGHT">$&nbsp;&nbsp;&nbsp;0.12</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT SIZE=3><P ALIGN="RIGHT">$&nbsp;&nbsp;&nbsp;0.20</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT SIZE=3><P ALIGN="RIGHT">$&nbsp;&nbsp;&nbsp;0.27</FONT></TD>
</TR>
</TABLE>
</CENTER></P>

<FONT SIZE=3><P ALIGN="JUSTIFY"></P>
</FONT><P ALIGN="JUSTIFY">&nbsp;</P>
<FONT SIZE=3><P ALIGN="JUSTIFY">&nbsp;</P></FONT>
<P ALIGN="CENTER"><CENTER><TABLE BORDER CELLSPACING=1 CELLPADDING=7 WIDTH=369>
<TR><TD VALIGN="TOP" COLSPAN=3>
<B><FONT SIZE=3><P ALIGN="CENTER">Condensed Consolidated Balance Sheet Highlights<BR>
(in thousands) (unaudited):</B></FONT></TD>
</TR>
<TR><TD VALIGN="TOP" COLSPAN=3>&nbsp;</TD>
</TR>
<TR><TD WIDTH="58%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="42%" VALIGN="TOP" COLSPAN=2>
<FONT SIZE=3><P ALIGN="CENTER">As of the Period Ended<BR>
December 31</FONT></TD>
</TR>
<TR><TD WIDTH="58%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="22%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">   <U>2004</U></FONT></TD>
<TD WIDTH="19%" VALIGN="MIDDLE">
<U><FONT SIZE=3><P ALIGN="RIGHT">2003</U></FONT></TD>
</TR>
<TR><TD WIDTH="58%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="22%" VALIGN="MIDDLE">&nbsp;</TD>
<TD WIDTH="19%" VALIGN="MIDDLE">&nbsp;</TD>
</TR>
<TR><TD WIDTH="58%" VALIGN="MIDDLE">
<FONT SIZE=3><P>Cash and Cash Equivalents</FONT></TD>
<TD WIDTH="22%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$&nbsp;&nbsp;10,221</FONT></TD>
<TD WIDTH="19%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$&nbsp;&nbsp;&nbsp;8,100</FONT></TD>
</TR>
<TR><TD WIDTH="58%" VALIGN="MIDDLE">
<FONT SIZE=3><P>Working Capital</FONT></TD>
<TD WIDTH="22%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">   11,100 </FONT></TD>
<TD WIDTH="19%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">     7,024</FONT></TD>
</TR>
<TR><TD WIDTH="58%" VALIGN="MIDDLE">
<FONT SIZE=3><P> Long-term Debt</FONT></TD>
<TD WIDTH="22%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">          42</FONT></TD>
<TD WIDTH="19%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">     1,402</FONT></TD>
</TR>
<TR><TD WIDTH="58%" VALIGN="MIDDLE">
<FONT SIZE=3><P>Stockholders' Equity</FONT></TD>
<TD WIDTH="22%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">   32,730</FONT></TD>
<TD WIDTH="19%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">    26,808</FONT></TD>
</TR>
</TABLE>
</CENTER></P>

<FONT SIZE=3><P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&nbsp;</P><DIR>
<DIR>
<DIR>

<P ALIGN="JUSTIFY">Mediware provides clinical information systems for hospitals and integrated healthcare delivery systems. Its products include HEMOCARE LifeLine<FONT FACE="Symbol">&#228;</FONT>
, Hemocare&reg;, LifeLine&reg; and LifeTrak&reg; (blood bank), WORx&reg;, MediMAR&trade;, and MediCOE&trade; (medication management), Surgiware&trade; and Perioperative Solutions&trade; (operating room), as well as the JAC Stock Control System (pharmacy) in the United Kingdom. Mediware has over 1,100 systems installed in the U.S., Canada, the U.K., and elsewhere.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="CENTER">#&#9;&#9;#&#9;&#9;#</P>
</FONT><P ALIGN="JUSTIFY"></P>
<I><FONT FACE="CG Times,Times New Roman"><P ALIGN="JUSTIFY">Certain statements in this press release may constitute "forward-looking'' statements within the meaning of the Private Securities Litigation Reform Act of 1995, as the same may be amended from time to time (the ``Act'') and in releases made by the SEC from time to time. Such forward-looking statements are not based on historical facts and involve known and unknown risks, uncertainties and other factors disclosed in the Company's Annual Report on Form 10-K for the year ended June 30, 2004, which may cause the actual results of the Company to be materially different from any future results expressed or implied by such forward-looking statements. The Company disclaims any obligation to update its forward-looking statements. </P>
</I></FONT><P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="JUSTIFY">2/1/05</P></DIR>
</DIR>
</DIR>
</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "form8kfeb05.htm", "secsgml_size_bytes": 19271}]
{"company-data": {"conformed-name": "MEDIWARE INFORMATION SYSTEMS INC", "cik": "0000874733", "assigned-sic": "7373", "irs-number": "112209324", "state-of-incorporation": "NY", "fiscal-year-end": "0630"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-10768", "film-number": "05564935"}, "business-address": {"street1": "11711 WEST 79TH STREET", "city": "LENEXA", "state": "KS", "zip": "66214", "phone": "9133071000"}, "mail-address": {"street1": "11711 WEST 79TH STREET", "city": "LENEXA", "state": "KS", "zip": "66214"}}
FORM 8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 1, 2005
Mediware Information Systems, Inc.
(Exact name of registrant as specified in its charter)
New York                                 1-10768                                 11-2209324
(State or other jurisdiction
of incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
11711 West 79th Street, Lenexa, KS                                           66214
(Address of principal executive offices)
(Zip Code)
Registrant's telephone number, including area code
(913) 307-1000
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02       Results of Operations and Financial Condition
On February 1, 2005, the Company issued a press release announcing its
financial results for the quarter ended December 31, 2004.  The press release is
attached hereto as Exhibit 99.1.  This information shall not be deemed "filed"
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended,
and is not incorporated by reference into any filing of the Company, whether
made before or after the date of this report, regardless of any general
incorporation language in the filing.
Item 9.01        Financial Statements and Exhibits.
(c)                  Exhibits.
Exhibit 99.1    Press Release of Mediware Information Systems, Inc., dated February 1, 2005,
announcing its financial results for the quarter ended December 31, 2004.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MEDIWARE INFORMATION SYSTEMS, INC
Date:	February 1, 2005
By:
/s/ George J. Barry
George J. Barry
Chief Executive Officer and President
EXHIBIT INDEX
Exhibit No.
Description
99.1
Press Release of Mediware Information Systems, Inc., dated February 1, 2005, announcing its financial results for the quarter ended December 31, 2004.
EXHIBIT 99.1
Contact
George Barry
913/307-1000
www.mediware.com
Thomas Redington
203/222-7399
212/926-1733
www.redingtoninc.com
Mediware Reports Second Quarter Fiscal 2005 Results
LENEXA, KS FEB. 1 --
Mediware Information Systems, Inc. (Nasdaq: MEDW) said revenue for its second fiscal quarter ended December 31, 2004 was $9.2 million, up 1 percent from the year-ago quarter.  Net income was $949,000, or 12 cents per basic and diluted share, compared to $973,000, or 13 cents per basic and 12 cents per diluted share, a year ago.
The Company reported that new product launches underway at all its divisions are experiencing increased levels of prospective customer interest.
"Order flow and installs of new blood banking systems are increasing in accordance with internal targets," said George Barry, Mediware's CEO, "and we expect pharmacy system roll-outs in the U.K. to increase over sequential quarters.  The Company has increased its marketing focus which, in combination with the availability of referenceable Medication Management System (MediMAR™ and MediCOE™) installs, should move the Division toward achieving forecasted levels."
On a broader note, he added, "we were delighted to learn that the Bush administration last week renewed its pledge to accelerate broader adoption of computerized health and prescription records.  The national goal is to reduce medical errors, and that bodes well for Mediware's strategy and product lines."
Three and six months ended December 31, 2004 and 2003 Condensed Consolidated
Statement of Operations Highlights
(in thousands, except net income per share) (unaudited):
Three Months Ended
December 31
Six Months Ended
December 31
2004
2003
2004
2003
System Sales
$  2,676
$  3,102
$  5,217
$  5,840
Services
6,550
6,007
12,489
12,280
Total Revenue
9,226
9,109
17,706
18,120
Operating Expenses
7,717
7,634
15,165
14,737
Operating Income
1,509
1,475
2,541
3,383
Net Income
949
973
1,592
2,171
Net Income per Common Share:
Basic
$   0.12
$   0.13
$   0.20
$   0.29
Diluted
$   0.12
$   0.12
$   0.20
$   0.27
Condensed Consolidated Balance Sheet Highlights
(in thousands) (unaudited):
As of the Period Ended
December 31
2004
2003
Cash and Cash Equivalents
$  10,221
$   8,100
Working Capital
11,100
7,024
Long-term Debt
42
1,402
Stockholders' Equity
32,730
26,808
Mediware provides clinical information systems for hospitals and integrated healthcare delivery systems. Its products include HEMOCARE LifeLine
ä
, Hemocare®, LifeLine® and LifeTrak® (blood bank), WORx®, MediMAR™, and MediCOE™ (medication management), Surgiware™ and Perioperative Solutions™ (operating room), as well as the JAC Stock Control System (pharmacy) in the United Kingdom. Mediware has over 1,100 systems installed in the U.S., Canada, the U.K., and elsewhere.
#		#		#
Certain statements in this press release may constitute "forward-looking'' statements within the meaning of the Private Securities Litigation Reform Act of 1995, as the same may be amended from time to time (the ``Act'') and in releases made by the SEC from time to time. Such forward-looking statements are not based on historical facts and involve known and unknown risks, uncertainties and other factors disclosed in the Company's Annual Report on Form 10-K for the year ended June 30, 2004, which may cause the actual results of the Company to be materially different from any future results expressed or implied by such forward-looking statements. The Company disclaims any obligation to update its forward-looking statements.
2/1/05